The pathogenesis of cancer is often driven by local invasion and metastasis. Recently, mechanical properties of the tumor microenvironment have been identified as potent regulators of invasion and metastasis, while matrix metalloproteinases (MMPs) are classically known as significant enhancers of cancer cell migration and invasion. Here we have been able to sensitively measure MMP activity changes in response to specific extracellular matrix (ECM) environments and cell contractility states. A pancreatic cancer cell line, Panc-1 cells, up-regulate MMP activities between 3-and 10-fold with increased cell contractility. Conversely, they down-regulate MMP activities when contractility is blocked to levels seen with pan-MMP activity inhibitors.
ABBREVIATIONS

Extracellular matrix (ECM) Matrix metalloproteinase (MMP) S-MMP (secreted MMP) MT-MMP (membrane tethered MMP) HEP III (heparinase III)
INTRODUCTION
Pancreatic cancer is one the deadliest subtypes of cancer, with 5 year survival rates less than 5 % (1).
The poor prognosis results from the combination of few early symptoms and aggressive early spreading of cancer cells to distant sites, a process called metastasis (1, 2) . Metastasis relies on multiple cellular mechanisms such as directed cell migration and extracellular matrix (ECM) remodeling (3) . Remodeling of the tissue microenvironment surrounding the primary tumor includes secretion of ECM and force-mediated rearrangement of the ECM structure, however much attention has been given to degradation of the ECM through the secretion of proteinases. Matrix metalloproteinases (MMPs) are the primary enzymes responsible for ECM remodeling and have long been associated with cancer cell migration and metastasis (4) .
MMPs are a family of 25 zinc-dependent proteinases that have wide substrate specificities for a variety of ECM proteins. The family is split into two major groups, soluble MMPs that are secreted from cells into the extracellular space and membrane-associated MMPs that are often tethered to the cell's plasma membrane through a transmembrane domain (4, 5) . Some secreted MMPs can also localize to the plasma membrane through their interaction with cell surface proteins (6, 7) . The precise regulation of each MMP family member remains vague, but it has been shown that MMPs perform specific roles in the cancer microenvironment (4, 8) .
Increased MMP expression has been demonstrated in a variety of cancers and often increased MMP expression results in increased metastatic potential (9) (10) (11) (12) . However, cues in the tumor microenvironment can lead to an upregulation of MMP activity separate from MMP expression through enhanced secretion or post-translational modification (13, 14) . This has led many researchers to investigate these stimulatory cues as upstream drivers of MMP activity and tumor invasion.
Recently, mechanical properties of the tumor microenvironment have gained much attention as potent drivers of invasion (15) (16) (17) (18) (19) (20) . Primary tumor tissue is often stiffer than normal tissue (17, 21) . This increase in stiffness is the result of cellular contractility coupled with increased ECM crosslinking (17, 18, 20) . Stiff ECM matrices often have smaller pores, but crosslinking itself does not affect pore size (19) . Cells can conceivably remodel the matrix and expand pores by exerting traction force using intracellular contractility that is generated through myosin II activity, a mode of migration referred to as amoeboid (22) (23) (24) . Indeed, increased traction force, has been shown to increase metastatic potential (24) (25) (26) . However, if the ECM network is stably crosslinked, MMP activity is required for cells to squeeze through pores (27, 28) , a mode of migration referred to as mesechymal. Consequently, the cell must sense chemical crosslinks in the ECM and tune its MMP activity appropriately. One interesting hypothesis posits that the cell tunes MMP activity through sensing the mechanical properties of the ECM (29) (30) (31) .
Mechanical properties of the ECM are sensed through ECM receptors called integrins (32, 33) . Integrins link the ECM with the actin cytoskeleton and actomyosin contractility within the cell. In addition to integrins, heparan sulfate proteoglycans (HSPG) like syndecans are important too (34) . Syndecans contain heparan sulfate groups on the outside of the cell that have been shown to be required for mechanotransduction in several cell types (35, 36) . In addition, heparan sulfate groups are known to be necessary in order to activate contractility regulators, such as Rho GTPases (37, 38) . On rigid substrates, Rho GTPases increase contractility by activating Rho-kinase, which in turn increases myosin II phosphorylation through a variety of mechanisms.
Importantly, Rho and ROCK overexpression has been linked to malignant transformation of cancer cells, implicating a role for cellular contractility in response to ECM mechanics in metastasis (39) . At first glance, enhanced contractility and force transmission by the cell might simply allow the cell to better rearrange the ECM, but perhaps there is an additional role in ECM degradation. Indeed, changes in MMP expression occur in response to changes in contractility (40) (41) (42) (43) (44) (45) (46) , but expression changes do not always indicate changes in MMP activity (47) . In addition, mechanical force, like that induced by cellular contractility, can act to alter the MMP cleavage rate of collagen due to a presumed change in conformation of the collagen substrate (48, 49) .
However, to date there is little information on whether intrinsic changes in MMP activity separate from substrate conformational changes are regulated by the cell's ability to transmit force. This ability to transmit force is driven by cellular contractility, the mechanical properties of the ECM and the cell adhesion to the ECM through receptors.
Here we demonstrate for the first time evidence that links cellular contractility, ECM mechanical properties and adhesion to MMP activity. We investigated secreted MMP (S-MMP) and membrane-tethered MMP (MT-MMP) activities in normal epithelial, breast cancer and pancreatic cancer cell lines under a variety of conditions using self-quenched cleavage peptides. In this article we show that in Panc-1 cells, increasing cellular contractility upregulates MMP activity. Conversely, decreasing cellular contractility downregulates MMP activity and to similar extents as the proteinase inhibitor, marimastat. Similar, but attenuated responses are seen in BxPC-3, AsPC-1 and MDA-MB-231 cells. However, in Panc-1 cells this regulation of MMP activity depends on the stiffness of the substrate. MMP activity on stiff substrates cannot increase after treatment with a contractility enhancer. In addition, MMP activity on soft substrates cannot be decreased by treatment with contractility inhibitors. Stiffening the ECM, by increasing the ECM concentration or crosslinking density using transglutaminase, increases MMP activity in Panc-1 cells, but BxPC-3 and AsPC-1 cells show an opposite behavior. Finally, mechanically stimulated MMP activity requires heparan sulfate groups, suggesting a role for heparan sulfate proteoglycans such as syndecans in sensing mechanics and tuning MMP activity.
MATERIALS & METHODS
Cell Culture
Human pancreatic cancer (Panc-1, BxPC-3, and AsPC-1, ATCC, Manassas, VA, USA), human keratinocyte (HaCat), and human breast cancer (MDA-MB-231, ATCC, Manassas, VA, USA) cells were used for all experiments as indicated. Panc-1, HaCat and MDA-MB-231 cultures were maintained using DMEM with phenol red + 10% FBS, 2% GlutaMAX, and 1% penicillin/streptomycin. BxPC-1 and AsPC-1 cultures were maintained using RPMI with phenol red + 10% FBS and 1% penicillin/streptomycin. All cells were harvested using trypsin (Life Technologies, Grand Island, NY, USA).
Absorbed & Gelled Collagen
Absorbed coatings of 0.1 mg/ml rat-tail collagen type I (Life Technologies, Grand Island, NY, USA) diluted in 0.5 M acetic acid were used. 
MMP Activity Assays
Cells were harvested with trypsin and then counted on a hemocytometer. Low density experiments for membrane-tethered MMP (MT-MMP) activity assays were all carried out at approximately 25,000 cells/well and high density experiments for secreted MMP (S-MMP) activity assays ranged between 100,000 and 200,000 cells/well. These cell densities resulted in confluences of 25% and 100% respectively. Cells were suspended in serum-free media with or without drug treatments for 1 hour, after which 100 µL (on adsorbed collagen substrates) or 50 µL (on collagen gel substrates) were transferred to a high-binding ( Upon cleavage this quenching is released and the fluorescence dramatically increases. MMP activity during spreading was measured during the first hour after plating and MMP activity after cells have spread were measured between the third and fourth hour after plating.
Fluorescence of the sample and background was excited at 320 nm and collected at 405 nm every 40 seconds using a BioTech SynergyMx micro plate-reader ( 
RESULTS
Matrix metalloproteinase (MMP) activity in pancreatic cancer cells is an increasing, but saturating function of contractile state
While there is some indication that altering contractility can change the expression and/or secretion of MMPs (40) (41) (42) (43) (44) (45) (46) or localized ECM degradation (29, 30) and that tension can lead to either enhanced or diminished collagen degradation (48, 49), we were interested in examining whether the contractile state of the cell regulates MMP activity in intact live cells. Two commercially available self-quenched MMP peptide substrates were used to measure either secreted MMP activity (S-MMP) or membrane tethered MMP activity (MT-MMP). Before cleavage these self-quenched peptides exhibit a low fluorescence which increases upon cleavage (Fig. S1 ). Panc-1 cells were plated on collagen for one hour. Media and cells were separated and MMP activity was measured using each of the two quenched cleavage peptides. S-MMP activity in the media was ~6-fold higher than that in the cells. Conversely, MT-MMP activity in the cells was ~6-fold higher than in the media, demonstrating an ability to measure either secreted or membrane tethered MMP activity (Fig 1) . These levels are statistically significant because the error bars do not overlap. Throughout the entire article error bars represent 95% confidence intervals. Consequently, non-overlapping error bars represent statistically significance to 95%. In order to optimize the MMP activity response, cells were plated at both high and low cell densities and both S-MMP and MT-MMP activity was measured. S-MMP activity on a per cell basis was higher when cells were densely plated as compared to sparsely plated (Fig. S2) . Conversely, MT-MMP activity on a per cell basis was lower when cells were densely plated as compared to sparsely plated (Fig. S2) . Therefore, we measured S-MMP and MT-MMP activity at high and low cell densities, respectively, for the remainder of the experiments. S-MMP and MT-MMP activity was also investigated at two time points, during the first hour after plating, and during the third hour after plating. Cells were plated on adsorbed collagen and then thoroughly rinsed to dislodge any non-attached cells at one and three hours. After rinsing, cells were fixed and stained for F-actin. Fewer cells were attached at one hour, and the cells that were attached were much less spread for both Panc-1 and a non-tumorigenic epithelial line (HaCat) (Fig. 2A) . Consequently, the one hour time point was identified as the spreading condition and the three hour time point was identified as the spread condition. A legend of the schematics used to describe the experimental conditions throughout the paper is shown in Fig. 1B .
Spreading Panc-1 cells showed a decrease in S-MMP activity with contractility inhibitors, Y-27632 (Y), ML-7 (ML) and blebbistatin (B), but S-MMP activity could not be further increased with the contractility enhancer, calyculin A (CA) (Fig 2B) . The decrease due to inhibition of contractility with either blebbistatin or Y-27632 matched closely to that seen with the pan MMP inhibitor, marimastat (M) (Fig. 2B) . HaCat cells, a non-tumorigenic cell line, showed an insensitive MMP activity response to contractility inhibitors or enhancers (Fig. 2B) . The change in MMP activity due to these contractility inhibitors and enhancers was not caused by direct inhibition of MT1-MMP activity as these inhibitors and enhancers did not block in vitro cleavage of the peptide substrate (Fig. S3) . Spread Panc-1 and HaCat cells showed similar qualitative responses of S-MMP activity to contractility inhibitors and enhancers (Fig. 2C) . However, marimastat, Y-27632 and blebbistatin blocked S-MMP activity to a greater extent (Fig. 2C ). In addition, two other pancreatic cancer cell lines BxPC-3
and AsPC-1 cells showed a more attenuated response post spreading to contractility inhibitors and enhancers, however, it is evident that increasing contraction increased S-MMP activity (Fig. 2D) . No difference in BxPC-3
or AsPC-1 cells was seen during spreading (data not shown). MT-MMP activity showed a similar dependence on the contractile state of the cell as did S-MMP activity with the exception that during spreading marimastat, Y-27632 and blebbistatin blocked MT-MMP activity equally as well as ML-7 ( Fig 2E&F) . In addition, MT-MMP activity under control or calyculin A treatment was increased after spreading when compared to MT-MMP activity during spreading. (Fig 2E&F) . The two other pancreatic cancer cell lines again showed small, but a statistically significant increase in MT-MMP activity with increased contraction after spreading. No difference in BxPC-3 or AsPC-1 cells was seen during spreading (data not shown).
Though contractile force seems to dramatically alter MMP activity in Panc-1 cells and marginally alter MMP activity in BxPC-3 and AsPC-1 cells plated on adsorbed collagen I, this ECM condition is quite different from what is seen in vivo. One difference is the stiffness of the substrate. Tissue culture plastic like that used in this study is stiff and has a Young's modulus of ~ 1 GPa, whereas a 1 mg/mL collagen gel is soft and has a
Young's modulus of ~ 0.2 kPa. This decrease (increase) in substrate stiffness is sensed by the cell and results in a decrease (increase) in cell contractility (32) . Because Panc-1 cells increase their contractility on stiff substrates, perhaps the extremely stiff environment of the tissue culture plastic saturates the contractility under control conditions. Therefore, we conducted the same experiments on 1 mg/mL collagen gels. On these gels, S-MMP and MT-MMP activity showed no great decrease in MMP activity after either treatment with marimastat or contractility inhibitors with the exception of S-MMP activity in spreading cells (Fig. 3) . However, treatment with the contractility enhancer calyculin A did show a dramatic increase in MMP activity with the exception of S-MMP activity in spreading cells (Fig. 3) . This suggests that on stiff substrates MMP activity can be decreased by contractility inhibitors, but MMP activity is saturated and cannot be increased further by contractility enhancers. However, if cells are plated on soft substrates, MMP activity is low and cannot be decreased with contractility inhibitors, however contractility enhancers can increase MMP activity. In order to test this view, cells were plated on 5 mg/mL collagen gels, which are stiffer than 1 mg/mL collagen gels, but softer than absorbed collagen on plastic. Cells display an intermediate behavior, where both contractility inhibitors and enhancers can modulate MMP activity (Fig. S4) .These consistent changes in MMP activity in response to contractility inhibitors and enhancers on absorbed and gelled collagen were not seen in non-tumorigenic HaCat cells or a breast cancer cell line (MDA-MB-231) and were attenuated, but statistically significant in BxPC-3
and AsPC-1 cells (Fig. 2, 3 , S4 and S5).
MMP activity in pancreatic cancer cells increases with increased ECM stiffness
Since contractility inhibitors and enhancers significantly regulate MMP activity in Panc-1 cells and to a lesser extent in BxPC-3 and AsPC-1 cells, we then investigated whether ECM stiffness regulated MMP activities. One way in which to tune collagen gel stiffness is through the gelling collagen concentration. Low collagen concentrations generate soft gels, whereas high collagen concentrations generate stiffer gels. MMP activities in different cell lines were measured in cells plated on various collagen gel concentrations. As collagen concentration increased, Panc-1 cells show a significantly higher S-MMP activity, while HaCat and MDA-MB-231 cells display no response during spreading (Fig 4A and S6A ). MT-MMP activity also increased with higher collagen gel concentration during spreading in Panc-1 cells, though less significantly. HaCat and MDA-MB-231 cells again showed no response during spreading (Fig 4B and S6B) . Interestingly, the response to increasing stiffness differed qualitatively between the three pancreatic cancer cell lines after spreading ( Fig   4C&D) . Collagen gels of 1 mg/ml are less stiff than gels of 5 mg/ml, which are less stiff than collagen adsorbed to plastic. As stiffness increased, Panc-1 cells increased their MMP activity, but both BxPC-3 and AsPC-1 cells decreased their MMP activity. HaCat cells remain roughly the same (Fig 4C&D) . However, this is not a clear demonstration of the importance of ECM stiffness on regulating MMP activity, because changes in the collagen density, a possibly important determinant of MMP activity, are used to change substrate stiffness.
Consequently, we used glutaraldehyde and transglutaminase to crosslink gelled collagen and increase the stiffness of the gel without changing collagen concentration. This allowed, for the decoupling of ECM density and stiffness.
We first determined whether crosslinking using glutaraldehyde, which stiffens collagen matrices (52-54), upregulates MMP activity. There were marginal, but statistically significant increases in MMP activity on glutaraldehyde treated collagen gels (1 mg/ml) (Fig 5A) . In addition, transglutaminase was added to a low concentration collagen gel (1 mg/mL) and cells were seeded on these crosslinked gels and compared to the uncrosslinked gels. Panc-1 cells showed no change in S-MMP activity and a decrease in MT-MMP activity on crosslinked gels during spreading (Fig. 5B) . Interestingly, S-MMP and MT-MMP activities both increased dramatically in spread Panc-1 cells on crosslinked gels (Fig 5B) . In order to determine if this increase in MMP activity was dependent on the contractile state of the cell we treated cells seeded on crosslinked gels with contractility inhibitors and enhancers. Increasing contractility with calyculin A could not further increase MMP activity from the control on crosslinked gels. However, both S-MMP and MT-MMP activities displayed significant inhibition with contractility inhibitors to levels seen with a proteinase inhibitor, demonstrating that the increase in MMP activity due to crosslinking is primarily a mechanical effect and is dependent on changes in cellular contractility (Fig 5C&D) .
Pancreatic cells sense ECM stiffness, modulating MMP activities, via heparan sulfate groups
Considering that ECM mechanics regulate MMP activities and their response to contractile state, we then investigated how cells sense these changes in ECM mechanics in order to tune their MMP activities. Panc-1 cells were treated with Heparinase III (HEP III), a bacterial-derived lyase for heparan sulfate groups and plated them on high collagen concentration gels (5 mg/ml). During spreading and after cells spread, HEP III treatment decreased S-MMP activity, but had no effect on MT-MMP activities in Panc-1 cells (Fig 6A) . We then investigated if HEP III treatment could affect MMP activity responses to crosslinked gels. Spread Panc-1 cells on transglutaminase-crosslinked collagen gels (1 mg/ml) that were treated with HEP III showed a significant decrease in both S-MMP and MT-MMP activities from what had previously been seen on crosslinked gels alone. The activity was lowered to similar levels seen on low concentration gels (1 mg/ml) without crosslinking treatment (Fig 6 B&C) .
DISCUSSION
Here we demonstrate a link between ECM mechanical properties and MMP activity that is mediated by cellular myosin II-dependent contractility and HSPG-dependent adhesion in Panc-1 cells. Invading tumor cells from the primary tumor must be able to sense the density of crosslinks in the ECM, because a highly crosslinked ECM contains pores that must be opened by active MMPs in order for cell migration to proceed (55) . Because the mechanical properties of the ECM are set in part by the crosslinking density, they constitute a potential signal for MMP activity regulation. A higher density of crosslinking results in a stiffer matrix, which in turn activates MMP activity. However, cells may also want to avoid over degradation of the matrix, given its requirement as a scaffold for migration. Consequently, when the crosslinked ECM network is cut and the ECM softens, MMP activity must be shut down. This gives the cell a regulated, dynamic feedback system that allows for tunable MMP activity to meet the needs of the cell under all ECM conditions. While MMP transcription or translation has been shown to be altered in response to changes in the mechanical environment, these changes have tended to occur over long timescales (40) (41) (42) (43) (44) (45) (46) . This suggests that the mechanical cue impacts a posttranslational process. This post-translational process changes MMP activity and depends on both contractility and adhesion in order to function specifically and dynamically.
The necessary requirement of contractility and adhesion in order to sense mechanical properties of the surrounding environment is well-established. However, the observation that increasing contractility in soft environments leads to upregulated MMP activity is novel. Indeed, cancer cells with higher Rho GTPase signaling, a driver of enhance contractility, tend to be more invasive (56) . In addition to contractility, adhesion through integrins and HSPGs is necessary for MMP upregulation in response to mechanical signals in 2D
environments (35, 36) . The response in 3D environments is less well understood, but a link between HSPGs and
MMPs has been proposed (57) . What is the mechanism by which MMP activity is upregulated or downregulated as the cell contractile state changes?
Though not investigated here, there are a variety of mechanisms that could explain how cells specifically What explains this difference in MMP activity between pancreatic cancer cell lines? Perhaps sensitivity to the matrix stiffness at the level of MMP activity correlates with or causes pancreatic tumor invasion (Fig. 7) .
Certainly, matrix stiffness has been linked to invasion (17, 66) . This might explain why Panc-1 cells, which MMP activity measured at high density after cells have spread on 1 mg/ml collagen gels (1), 5 mg/ml collagen gels (5) and 0.1 mg/ml collagen physisorbed to plastic (P). D, MT-MMP activity measured at low density after cells have spread on 1 mg/ml collagen gels (1), 5 mg/ml collagen gels (5) and 0.1 mg/ml collagen physisorbed to plastic (P). Error bars are 95% confidence intervals (n = 6).
Figure 5: Crosslinked Gels Increase MMP Activities in Spread Cells
A, MMP activity measured in Panc-1 cells after spreading on glutaraldehyde treated 1 mg/ml collagen gels. B, MMP activity measured in Panc-1 cells during or after spreading with S-MMP activity measured with high cell density and MT-MMP activity measured at low cell density. Collagen gels (1 mg/mL) were gelled in the presence of 50 µg/ml transglutaminase (n = 4). C, S-MMP activities are measured at a high cell density in Panc-1 cells 3 hours after plating on 1 mg/ml collagen gels, 1 mg/ml collagen gels + 50µg/ml transglutaminase or on 1 mg/ml collagen gels + 50µg/ml transglutaminase under various drug treatments (M: marimastat (10 M), Y: Y-27632 (10 M), B: blebbistatin (10 M) and CA: calyculin A (1 M)) (n = 3). D, MT-MMP activities are measured at low density in Panc-1 cells 3 hours after plating on 1 mg/ml collagen gels, 1 mg/ml collagen gels + 50µg/ml transglutaminase or on 1 mg/ml collagen gels + 50µg/ml transglutaminase under various drug treatments (M: marimastat (10 M), Y: Y-27632 (10 M), B: blebbistatin (10 M) and CA:
calyculin A (1 M)) (n = 3). Error bars are 95% confidence intervals.
Figure 6: Cells Sense Collagen Gel Crosslinking Via Heparan Sulfate Groups.
A, MMP activity measured in Panc-1 cells during or after spreading with S-MMP activity measured at high cell density and MT-MMP activity measured at low cell density. Cells were plated on 5 mg/ml collagen gels with and without 3 µg/mL HEP III per well. B, S-MMP activities are measured in Panc-1 cells at high density 3 hours after plating on 1 mg/ml collagen gels, 1 mg/ml + 50 µg/ml transglutaminase and 1 mg/ml + 50 µg/ml transglutaminase after incubation with HEP III. C, MT-MMP activities are measured in Panc-1 cells at low density 3 hours after plating on 1 mg/ml collagen gels, 1 mg/ml + 50 µg/ml transglutaminase and 1 mg/ml + 50 µg/ml transglutaminase after incubation with HEP III. Error bars are 95% confidence intervals (n = 3). 
SUPPLEMENTARY FIGURES
Figure S2: Cell Density Effects on S-MMP and MT-MMP Activities
A, S-MMP activity measured at high cell density and MT-MMP activity measured at low cell density in different cell lines. Cells were plated on 0.1 mg/ml absorbed collagen. Error bars are 95% confidence intervals (n = 4). 
